KemPharm moves to Nasdaq Capital Market
BPC Staff Jan 22, 2020 | 9:11 pm
<1 min read time84 wordsAll Latest News, Insurance & Investments, Iowa News
KemPharm, the Coralville-based specialty pharmaceutical company, is striving to maintain its Nasdaq listing as the company’s stock has slumped below the required minimum of $1 per share, the Corridor Business Journal reported. Shares of KemPharm were trading Tuesday at 43 cents per share, down from a 52-week high of $2.85. The stock listing for KemPharm was moved to the Nasdaq Capital Market from the Nasdaq Global Market. The Nasdaq Capital Market is a trading tier for smaller companies that typically are raising capital.
Facebook Notice for EU! You need to login to view and post FB Comments!